Biotricity, Inc.
BTCY
$0.50
-$0.02-3.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 21.30% | 57.73% | 11.67% | -48.94% | 23.92% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -14.36% | -70.31% | 91.87% | 41.14% | -29.12% |
| Total Other Non-Cash Items | 38.61% | -85.92% | 131.73% | -38.63% | 94.92% |
| Change in Net Operating Assets | -3.42% | 355.76% | -92.47% | 356.83% | 17.60% |
| Cash from Operations | 77.81% | 73.42% | -28.17% | 10.74% | 45.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 106.90% | 23.11% | -67.57% | 330.46% | -85.83% |
| Total Debt Repaid | 1.77% | 65.68% | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -68.00% | 41.89% | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.67% | 50.00% | -- | 100.00% | -1.69% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.79% | -45.74% | -51.46% | 819.54% | -94.33% |
| Foreign Exchange rate Adjustments | 66.67% | 97.47% | -175.73% | 2,546.88% | -102.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.86% | 110.58% | -197.76% | 162.89% | -197.07% |
